Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-017781
Filing Date
2018-06-22
Accepted
2018-06-22 19:00:03
Documents
1
Period of Report
2018-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9122
  Complete submission text file 0000899243-18-017781.txt   10502
Mailing Address C/O CIVITAS THERAPEUTICS, INC. 190 EVERETT AVENUE CHELSEA MA 02150
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38533 | Film No.: 18915629

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

EIN.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations